skinny.

Latest / Eyewire News: The Podcast

Ocular Updates Plans for Axpaxli NDA for Wet AMD

Ocular Therapeutix provides a key update on its NDA plans for wet AMD drug candidate Axpaxli; Thea US launches a first-of-its-kind eye gel for glaucoma; and there were several recent milestones reached in the clinical development of novel drugs for a variety of ocular conditions.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.